S&P 500
7,376.86
+23.13
+0.31%
Dow
51,285.73
-237.37
-0.46%
Nasdaq
24,579.42
+264.42
+1.09%
NYSE Composite
23,950.37
-5.63
-0.02%
Russell 2000
2,754.11
+24.22
+0.89%
VIX
25.64
-2.54
-9.01%
TMDX · TransMedics Group, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
TransMedics Group, Inc. (TMDX)
NASDAQ NMS - GLOBAL MARKET
Health Care
$88.22
+19.31
(+28.02%)
● At close: November 6 at 4:00:00 PM EDT
$88.20
-0.04
(-0.05%)
Overnight:
9:32:46 PM EDT
DAY'S RANGE
$88.22
$76.62
$88.43
52-WEEK RANGE
$88.22
$60.10
$156.00
What's happening
- TMDX is up 28.02% today, trading at $88.22. — Live quote
- Volume today (256,242) is well below its 3-month average of 889,990. (Finnhub fundamentals)
- Last quarter's EPS beat estimates: $0.51 actual vs. $0.30 estimated (+71.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 9
Hold 5
Sell 0
Strong sell 0
Aggregate ratings for 2026-11-01 (19 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
TMDX
-27.46%
vs S&P 500
-35.29%
1-YEAR RETURN
TMDX
-29.40%
vs S&P 500
-39.09%
6-MONTH RETURN
TMDX
-7.05%
3-MONTH RETURN
TMDX
+5.19%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-11-05 (Q3 2026)
$0.51
Est. $0.30
BEAT +71.3%
2026-07-26 (Q2 2026)
$0.44
Est. $0.48
MISS -8.9%
2026-04-26 (Q1 2026)
$0.30
Est. $0.62
MISS -52.0%
2026-01-26 (Q4 2025)
$0.53
Est. $0.40
BEAT +32.9%
Valuation Measures & Ratios
Enterprise Value4$3.45B
Forward P/E560.21
PEG Ratio60.18
Price / Sales (TTM1)4.58
Price / Book74.43
EV4 / Revenue5.16
EV4 / EBITDA36.75
Profit Margin22.69%
Operating Margin12.21%
Return on Equity (ROE8)32.97%
Return on Assets (ROA9)12.35%
Avg Volume (3M)889,990
Quarterly history (5 periods)
| Measure | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $3.11B | $2.38B | $3.63B | $4.14B | $5.09B |
| P/E | 49.04 | 29.29 | 39.41 | 46.40 | 66.04 |
| Price/Sales | 4.37 | 3.58 | 5.88 | 7.47 | 9.71 |
| Price/Book | 5.64 | 4.59 | 7.36 | 11.64 | 15.99 |
| EV/Revenue | 4.45 | 3.61 | 5.90 | 7.48 | 9.71 |
| EV/EBITDA | 24.66 | 18.10 | 27.61 | — | — |
| ROE | 11.51% | 15.68% | 18.67% | 25.09% | 24.21% |
| ROA | 4.18% | 5.55% | 6.43% | 9.42% | 8.65% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short8,769,040
Change from Prior Settlement+2.54%
% of Float—
Days to Cover (Short Ratio)9.89
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 20.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 22.7%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -29.4%. Finnhub market metrics ↗
- Latest SEC filing is Form 10-Q, filed 2026-11-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on TMDX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $203.0M | $189.9M | $173.9M | $143.8M | $157.4M | $143.5M | $108.8M | $114.3M |
| Gross profit | $118.7M | $113.2M | $101.2M | $84.6M | $96.6M | $88.2M | $60.8M | $69.3M |
| Operating income | $28.1M | $23.7M | $13.3M | $23.3M | $36.6M | $27.4M | $3.9M | $12.5M |
| Net income | $17.1M | $14.7M | $7.3M | $24.3M | $34.9M | $25.7M | $4.2M | $12.2M |
| EPS (diluted) | $0.46 | $0.41 | $0.20 | $0.66 | $0.92 | $0.70 | $0.12 | $0.35 |
| EPS (basic) | $0.49 | $0.42 | $0.21 | $0.71 | $1.03 | $0.76 | $0.13 | $0.37 |
| Operating margin | $14 | $12 | $8 | $16 | $23 | $19 | $4 | $11 |
| Net margin | $8 | $8 | $4 | $17 | $22 | $18 | $4 | $11 |
Balance sheet
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.52B | $1.46B | $1.43B | $1.07B | $946.0M | $890.5M | $837.5M | $804.1M |
| Total liabilities | $967.2M | $946.3M | $940.8M | $595.3M | $590.8M | $572.4M | $571.2M | $575.5M |
| Stockholders' equity | $550.7M | $518.1M | $494.0M | $473.1M | $355.2M | $318.1M | $266.3M | $228.6M |
| Total current assets | $692.5M | $651.1M | $619.3M | $637.8M | $613.0M | $558.1M | $505.9M | $497.2M |
| Total current liabilities | $152.9M | $98.3M | $91.9M | $89.3M | $79.7M | $56.6M | $55.6M | $59.9M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $114.9M | $104.1M | $90.7M | $84.3M | $80.7M | $104.9M | $142.0M | $97.7M |
| Inventory | $58.4M | $54.1M | $49.9M | $48.9M | $44.5M | $38.9M | $43.4M | $46.6M |
| Property, plant & equipment | $376.5M | $365.3M | $361.6M | $327.7M | $313.0M | $312.3M | $311.2M | $286.0M |
| Goodwill | $18.0M | $11.5M | $11.5M | $11.5M | $11.5M | $11.5M | $11.5M | $11.5M |
| Intangible assets | $2.8M | $0 | $0 | $1.9M | $2.0M | $2.0M | $2.1M | $2.2M |
| Other non-current assets | $2.2M | $2.2M | $2.1M | $239.0K | $226.0K | $221.0K | $211.0K | $208.0K |
| Accounts payable | $10.1M | $12.9M | $11.2M | $10.3M | $12.2M | $9.5M | $10.6M | $10.3M |
| Deferred revenue (current) | $1.5M | $3.1M | $2.9M | $2.9M | $3.3M | $1.6M | $2.1M | $1.7M |
| Short-term debt | $54.8M | $20.0M | $15.0M | $10.0M | $5.0M | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $5.9M | $4.0M | $4.0M | — | — | — | — | — |
| Common stock & paid-in capital | $789.9M | $774.2M | $764.6M | $750.9M | $738.4M | $725.7M | $709.2M | $697.2M |
| Retained earnings | -$238.9M | -$256.0M | -$270.6M | -$277.9M | -$383.3M | -$407.7M | -$442.6M | -$468.2M |
| Accumulated other comprehensive income (loss) | -$306.0K | -$210.0K | $2.0K | $124.0K | $101.0K | $98.0K | -$327.0K | -$364.0K |
Cash flow
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $36.0M | $17.3M | $24.5M | $34.5M | $69.6M | $91.6M | -$2.9M | $19.7M |
| Investing cash flow | -$13.7M | -$7.1M | -$36.7M | -$15.5M | -$7.6M | -$9.1M | -$27.0M | -$13.6M |
| Financing cash flow | -$1.9M | $970.0K | $3.8M | $3.1M | $3.6M | $7.1M | $3.0M | $1.2M |
| Free cash flow | $27.6M | $10.2M | -$12.1M | $19.0M | $61.9M | $82.5M | -$29.9M | $6.1M |
| Capital expenditures | $8.4M | $7.1M | $36.7M | $15.5M | $7.6M | $9.1M | $27.0M | $13.6M |
| Depreciation & amortization | $10.8M | $10.2M | $11.9M | $7.5M | $6.8M | $6.7M | $6.1M | $5.7M |
| Share-based compensation | $12.6M | $8.6M | $10.0M | $9.4M | $9.1M | $9.4M | $9.0M | $10.8M |
| Deferred income taxes | $5.9M | $3.8M | $1.1M | -$83.5M | — | — | — | — |
| Change in accounts receivable | $8.1M | $13.4M | $6.5M | $3.6M | -$24.1M | -$37.5M | $44.1M | $7.8M |
| Change in inventory | $9.1M | $6.3M | $3.9M | $6.5M | $6.9M | -$3.7M | -$2.0M | -$4.1M |
| Change in accounts payable | -$4.8M | $1.6M | $1.1M | -$2.1M | $2.5M | -$1.2M | $781.0K | -$3.1M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $140.0K | $39.0K | $138.0K | $0 | $138.0K | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $605.5M | $441.5M | $241.6M | $93.5M | $30.3M |
| Gross profit | $362.8M | $262.1M | $154.1M | $65.3M | $21.2M |
| Operating income | $108.6M | $37.5M | -$28.7M | -$31.4M | -$39.4M |
| Net income | $190.3M | $35.5M | -$25.0M | -$36.2M | -$44.2M |
| EPS (diluted) | $4.87 | $1.01 | $-0.77 | $-1.23 | $-1.60 |
| EPS (basic) | $5.60 | $1.07 | $-0.77 | $-1.23 | $-1.60 |
| Operating margin | $18 | $8 | -$12 | -$34 | -$130 |
| Net margin | $31 | $8 | -$10 | -$39 | -$146 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.07B | $804.1M | $706.0M | $277.1M | $134.9M |
| Total liabilities | $595.3M | $575.5M | $568.8M | $89.8M | $67.0M |
| Stockholders' equity | $473.1M | $228.6M | $137.2M | $187.4M | $67.9M |
| Total current assets | $637.8M | $497.2M | $510.7M | $252.3M | $118.7M |
| Total current liabilities | $89.3M | $59.9M | $54.9M | $23.7M | $23.2M |
| Cash & equivalents | — | — | $394.8M | $201.2M | $25.6M |
| Marketable securities (current) | — | — | — | — | $66.9M |
| Accounts receivable | $84.3M | $97.7M | $63.6M | $27.6M | $5.9M |
| Inventory | $48.9M | $46.6M | $44.2M | $20.6M | $14.9M |
| Property, plant & equipment | $327.7M | $286.0M | $173.9M | $19.2M | $9.8M |
| Goodwill | $11.5M | $11.5M | $12.0M | — | — |
| Intangible assets | $1.9M | $2.2M | $2.4M | — | — |
| Other non-current assets | $239.0K | $208.0K | $62.0K | — | — |
| Accounts payable | $10.3M | $10.3M | $12.7M | $3.3M | $6.7M |
| Deferred revenue (current) | $2.9M | $1.7M | $2.0M | $241.0K | $250.0K |
| Short-term debt | $10.0M | — | — | — | — |
| Long-term debt | — | — | — | $58.7M | $35.2M |
| Common stock & paid-in capital | $750.9M | $697.2M | $641.1M | $666.3M | $510.5M |
| Retained earnings | -$277.9M | -$468.2M | -$503.7M | -$478.7M | -$442.4M |
| Accumulated other comprehensive income (loss) | $124.0K | -$364.0K | -$199.0K | -$225.0K | -$188.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $192.8M | $48.8M | -$13.0M | -$45.8M | -$28.9M |
| Investing cash flow | -$59.3M | -$129.3M | -$194.0M | $54.5M | $29.3M |
| Financing cash flow | $16.9M | $22.9M | $400.4M | $167.9M | $1.4M |
| Free cash flow | $133.6M | -$80.9M | -$164.9M | -$57.7M | -$32.4M |
| Capital expenditures | $59.3M | $129.7M | $151.8M | $11.9M | $3.5M |
| Depreciation & amortization | $27.2M | $19.8M | $8.2M | $3.5M | $1.8M |
| Share-based compensation | $36.9M | $33.2M | $19.8M | $10.3M | $6.9M |
| Deferred income taxes | -$83.5M | — | -$1.7M | — | — |
| Change in accounts receivable | -$13.9M | $34.3M | $33.8M | $21.7M | -$840.0K |
| Change in inventory | $7.7M | $8.4M | $28.1M | $8.0M | $4.9M |
| Change in accounts payable | -$19.0K | -$1.4M | $7.0M | -$3.3M | $5.1M |
| Purchases of investments | — | — | — | $10.5M | $72.0M |
| Debt issued | — | — | — | $58.5M | — |
| Debt repaid | — | — | — | $36.0M | — |
| Tax withholding on stock comp | $138.0K | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding TMDX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers44.4%
Shares Outstanding14,656,110,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,162,996,939 | $336.52B | 7.94% | +1.6% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 959,107,911 | $277.53B | 6.54% | +0.6% | 2026-06-30 |
| State Street Corp | 615,129,929 | $177.99B | 4.20% | +2.1% | 2026-08-07 |
| GEODE CAPITAL MANAGEMENT, LLC | 371,336,543 | $107.17B | 2.53% | +0.7% | 2026-08-12 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 334,119,156 | $96.68B | 2.28% | +0.8% | 2026-06-30 |
| FMR LLC | 325,348,754 | $94.14B | 2.22% | +5.8% | 2026-08-13 |
| Morgan Stanley | 242,614,238 | $70.20B | 1.66% | -0.8% | 2026-08-11 |
| Jpmorgan Chase & Co | 228,762,008 | $64.45B | 1.56% | -1.2% | 2026-08-12 |
| Berkshire Hathaway Inc | 227,917,808 | $65.95B | 1.56% | +0.0% | 2026-08-14 |
| NORGES BANK | 190,726,866 | $55.19B | 1.30% | +0.0% | 2026-08-12 |
| Invesco Ltd. | 187,965,529 | $54.39B | 1.28% | +157.9% | 2026-08-13 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 159,811,362 | $46.2M | 1.09% | -20.3% | 2026-08-14 |
| Northern Trust Corp | 157,785,381 | $45.66B | 1.08% | -0.9% | 2026-08-12 |
| Bank Of America Corp /De/ | 127,820,329 | $36.99B | 0.87% | +5.9% | 2026-08-14 |
| Goldman Sachs Group Inc | 111,744,105 | $32.33B | 0.76% | +4.8% | 2026-08-14 |
| Legal & General Group Plc | 105,208,881 | $30.44B | 0.72% | -2.7% | 2026-08-14 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 104,001,309 | $30.09B | 0.71% | -1.4% | 2026-08-13 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 101,374,121 | $29.33B | 0.69% | -0.9% | 2026-08-14 |
| Bank of New York Mellon Corp | 88,383,551 | $25.57B | 0.60% | -4.0% | 2026-08-06 |
| VANGUARD FIDUCIARY TRUST CO | 83,474,159 | $24.15B | 0.57% | -0.9% | 2026-06-30 |
| Nuveen, LLC | 74,873,332 | $21.67B | 0.51% | -4.6% | 2026-08-11 |
| Amundi | 70,758,208 | $20.47B | 0.48% | -3.2% | 2026-08-11 |
| Franklin Templeton Inc | 69,201,134 | $20.02B | 0.47% | +42.4% | 2026-08-04 |
| Royal Bank Of Canada | 65,402,666 | $18.92B | 0.45% | -2.3% | 2026-08-13 |
| Wells Fargo & Company/Mn | 59,910,539 | $17.34B | 0.41% | +2.0% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-11-17 to 2026-10-28
Recent transactions
- Insiders have net sold 8,288 shares over the last 182 days, across 1 purchase and 1 sale.
- Most recent: Araujo Fernando N. (See Remarks) — Grant / award of 22,969 shares on 2026-10-28.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)1,336 sh(1 txns)
Sales (open market)9,624 sh(1 txns)
Net Shares-8,288
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Araujo Fernando N. | See Remarks | Grant / award | 2026-10-28 | 22,969 |
| Weill David | Reporting person | Open market purchase | 2026-09-11 | 1,336 |
| TOBIN JAMES R | Reporting person | Gift | 2026-08-17 | 18,000 |
| Corcoran Nicholas | See remarks | Grant / award | 2026-07-10 | 11,727 |
| Hernandez Gerardo | Chief Financial Officer | Grant / award | 2026-07-10 | 17,246 |
| Hassanein Waleed H | President & CEO | Grant / award | 2026-07-10 | 49,669 |
| Gunderson Thomas J. | Reporting person | Option exercise | 2026-06-15 | 19,285 |
| Lovell Stephanie | Reporting person | Grant / award | 2026-05-20 | 2,922 |
| RAINES MERILEE | Reporting person | Grant / award | 2026-05-20 | 2,922 |
| Basile Edward M | Reporting person | Grant / award | 2026-05-20 | 2,922 |
| Kania Edwin | Reporting person | Grant / award | 2026-05-20 | 2,922 |
| Forsyth Matthew S. | See Remarks | Grant / award | 2026-05-19 | 15,409 |
| Ranganath Anil P. | See remarks | Open market sale | 2026-03-02 | 864 |
| Cecere Giovanni | Chief Commercial Officer | Grant / award | 2026-02-18 | 11,082 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-28 | Araujo Fernando N. | See Remarks | Grant / award | 22,969 | $0.00 |
| 2026-09-11 | Weill David | Reporting person | Open market purchase | 1,336 | $81.63 |
| 2026-08-17 | TOBIN JAMES R | Reporting person | Gift | 18,000 | $0.00 |
| 2026-07-10 | Corcoran Nicholas | See remarks | Grant / award | 11,727 | $0.00 |
| 2026-07-10 | Hernandez Gerardo | Chief Financial Officer | Grant / award | 17,246 | $0.00 |
| 2026-07-10 | Hassanein Waleed H | President & CEO | Grant / award | 49,669 | $0.00 |
| 2026-06-15 | Gunderson Thomas J. | Reporting person | Option exercise | 19,285 | $2.21 |
| 2026-06-15 | Gunderson Thomas J. | Reporting person | Open market sale | 9,624 | $75.06 |
| 2026-05-20 | Lovell Stephanie | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | Weill David | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | RAINES MERILEE | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | Gunderson Thomas J. | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | Basile Edward M | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | TOBIN JAMES R | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-20 | Kania Edwin | Reporting person | Grant / award | 2,922 | $0.00 |
| 2026-05-19 | Forsyth Matthew S. | See Remarks | Grant / award | 15,409 | $0.00 |
| 2026-03-04 | Lovell Stephanie | Reporting person | Open market sale | 1,193 | $149.62 |
| 2026-03-04 | Weill David | Reporting person | Option exercise | 3,571 | $14.20 |
| 2026-03-04 | Weill David | Reporting person | Open market sale | 3,571 | $146.82 |
| 2026-03-04 | Hernandez Gerardo | Chief Financial Officer | Option exercise | 1,324 | $77.12 |
| 2026-03-04 | Hernandez Gerardo | Chief Financial Officer | Open market sale | 1,324 | $147.21 |
| 2026-03-04 | Hernandez Gerardo | Chief Financial Officer | Option exercise | 5,912 | $69.84 |
| 2026-03-04 | Hernandez Gerardo | Chief Financial Officer | Open market sale | 5,912 | $147.21 |
| 2026-03-02 | Hernandez Gerardo | Chief Financial Officer | Open market sale | 375 | $139.12 |
| 2026-03-02 | Ranganath Anil P. | See remarks | Open market sale | 864 | $139.12 |
| 2026-03-02 | Corcoran Nicholas | See remarks | Open market sale | 2,966 | $139.12 |
| 2026-02-18 | Cecere Giovanni | Chief Commercial Officer | Grant / award | 11,082 | $0.00 |
| 2026-01-23 | Corcoran Nicholas | See remarks | Tax withholding | 984 | $135.30 |
| 2025-12-04 | Hernandez Gerardo | Chief Financial Officer | Open market sale | 920 | $139.62 |
| 2025-12-03 | Weill David | Reporting person | Option exercise | 5,000 | $14.20 |
| 2025-12-03 | Weill David | Reporting person | Open market sale | 5,000 | $138.64 |
| 2025-11-25 | Ranganath Anil P. | See remarks | Option exercise | 3,000 | $93.88 |
| 2025-11-25 | Ranganath Anil P. | See remarks | Open market sale | 3,000 | $145.22 |
| 2025-11-17 | Hassanein Waleed H | President & CEO | Open market purchase | 8,775 | $114.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-09 02:45 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-11-05 | 10-Q | 2026-09-30 | View on SEC.gov → |
| 2026-11-05 | 8-K | 2026-11-05 | View on SEC.gov → |
| 2026-10-30 | 4 | 2026-10-28 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-09-11 | View on SEC.gov → |
| 2026-09-10 | 8-K | 2026-09-10 | View on SEC.gov → |
| 2026-08-17 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-14 | 4 | 2026-07-10 | View on SEC.gov → |
| 2026-07-14 | 4 | 2026-07-10 | View on SEC.gov → |
| 2026-07-14 | 4 | 2026-07-10 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-15 | View on SEC.gov → |
Recent news
Headlines about TMDX (TransMedics Group, Inc.). Links open the publisher — we don’t host full articles.
-
TMDX Nov 2026 62.000 put (TMDX261106P00062000) stock price, news, quote and history
Yahoo Finance UK · 2026-11-08 -
Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs Alive
Yahoo · 2026-11-07 -
TransMedics Group (NASDAQ:TMDX) Stock Price Breaks Above 50-Day Moving Average - What's Next?
MarketBeat · 2026-11-07 -
TransMedics Group (NASDAQ:TMDX) Raised to "Hold" at Wall Street Zen
MarketBeat · 2026-11-07 -
Transmedics Group Stock Price Forecast. Should You Buy TMDX?
StockInvest.us · 2026-11-06 -
TransMedics Group (TMDX) Shares Surge Over 25% Following Strong Q3 Results
GuruFocus · 2026-11-06 -
TMDX Maintained by Needham -- Price Target Raised to $110
GuruFocus · 2026-11-06 -
TMDX Maintained by Canaccord Genuity -- Price Target Raised to $120
GuruFocus · 2026-11-06
No headlines in this category right now — try “All”.